Jon Paul Gockerman | Scholars@Duke

Jon Paul Gockerman
Professor Emeritus of Medicine

My research effort is involved in clinical research studies through the CALGB as well as several sub interests. My interest is the use of 131I MIBG in the treatment of carcinoids. We have completed a dose seeking study to determine the maximum tolerated dose. This has been completed and this paper is in preparation for publication. We plan to do an additional study of randomization in patients with this agent to see if we can determine an objective response rate in a controlled group of patients.

The secondary issue is that of high dose chemotherapy in lymphoma. We have completed a study involving use of high dose chemotherapy in a transplant setting in patients with refractory lymphoma. This study has treated over 100 patients and is in the process of being written up.

Current Appointments & Affiliations

Professor Emeritus of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2013

Contact Information

25154 Morris Bldg, Durham, NC 27710
Duke Box 3872, Durham, NC 27710
gocke002@mc.duke.edu (919) 684-8964

Background
Education, Training, & Certifications
- M.D., University of Chicago 1967
Duke Appointment History
- Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 1983 - 2014
- Professor of Medicine, Medicine, Hematological Malignancies, Medicine 1994 - 2012
- Associate Professor of Medicine in the Department of Medicine, Medicine, Medical Oncology, Medicine 1984 - 1994
Research
Selected Grants
- Cancer And Leukemia Group B awarded by National Institutes of Health 1993 - 1998
Publications & Artistic Works
Selected Publications
- Academic Articles
  - DiLillo, DJ, Weinberg, JB, Yoshizaki, A, Horikawa, M, Bryant, JM, Iwata, Y, Matsushita, T, Matta, KM, Chen, Y, Venturi, GM, Russo, G, Gockerman, JP, Moore, JO, Diehl, LF, Volkheimer, AD, Friedman, DR, Lanasa, MC, Hall, RP, and Tedder, TF. "Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function." Leukemia 27, no. 1 (January 2013): 170-182. Full Text Link to Item
  - Morris, TA, DeCastro, CM, Diehl, LF, Gockerman, JP, Lagoo, AS, Li, Z, Moore, JO, Rizzieri, DA, and Rao, AV. "Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia." Leuk Res 37, no. 1 (January 2013): 28-31. Full Text Link to Item
  - Rao, AV, Rizzieri, DA, DeCastro, CM, Diehl, LF, Lagoo, AS, Moore, JO, and Gockerman, JP. "Phase I study of dose dense induction and consolidation with gemtuzumab ozogamicin and high dose cytarabine in older adults with AML." Journal of Geriatric Oncology 3, no. 3 (July 1, 2012): 220-227. Full Text
  - Vlahovic, G, Meadows, KL, Uronis, HE, Morse, MA, Blobe, GC, Riedel, RF, Zafar, SY, Alvarez-Secord, A, Gockerman, J, Starodub, AN, Ready, NE, Anderson, EL, Bendell, JC, and Hurwitz, HI. "A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors." Cancer Chemotherapy and Pharmacology 70, no. 1 (July 2012): 95-102. Full Text
  - Lanasa, MC, Davis, PH, Datto, M, Li, Z, Gockerman, JP, Moore, JO, DeCastro, CM, Friedman, DR, Diehl, LF, Rehder, C, Cook, H, Daugherty, FJ, Matta, KMB, Weinberg, JB, and Rizzieri, D. "Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia." Leukemia & Lymphoma 53, no. 2 (February 2012): 218-224. Full Text
  - Ettinger, DS, Agulnik, M, Cates, JMM, Cristea, M, Denlinger, CS, Eaton, KD, Fidias, PM, Gierada, D, Gockerman, JP, Handorf, CR, Iyer, R, Lenzi, R, Phay, J, Rashid, A, Saltz, L, Shulman, LN, Smerage, JB, Varadhachary, GR, Zager, JS, Zhen, WK, and National Comprehensive Cancer Network, . "NCCN Clinical Practice Guidelines Occult primary." Journal of the National Comprehensive Cancer Network : Jnccn 9, no. 12 (December 2011): 1358-1395. Full Text
  - Christensen, DJ, Chen, Y, Oddo, J, Matta, KM, Neil, J, Davis, ED, Volkheimer, AD, Lanasa, MC, Friedman, DR, Goodman, BK, Gockerman, JP, Diehl, LF, de Castro, CM, Moore, JO, Vitek, MP, and Weinberg, JB. "SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target." Blood 118, no. 15 (October 13, 2011): 4150-4158. Full Text Link to Item
  - Lanasa, MC, Allgood, SD, Slager, SL, Dave, SS, Love, C, Marti, GE, Kay, NE, Hanson, CA, Rabe, KG, Achenbach, SJ, Goldin, LR, Camp, NJ, Goodman, BK, Vachon, CM, Spector, LG, Rassenti, LZ, Leis, JF, Gockerman, JP, Strom, SS, Call, TG, Glenn, M, Cerhan, JR, Levesque, MC, Weinberg, JB, and Caporaso, NE. "Immunophenotypic and gene expression analysis of monoclonal B-cell lymphocytosis shows biologic characteristics associated with good prognosis CLL." Leukemia 25, no. 9 (September 2011): 1459-1466. Full Text Link to Item
  - Schuster, SJ, Neelapu, SS, Gause, BL, Janik, JE, Muggia, FM, Gockerman, JP, Winter, JN, Flowers, CR, Nikcevich, DA, Sotomayor, EM, McGaughey, DS, Jaffe, ES, Chong, EA, Reynolds, CW, Berry, DA, Santos, CF, Popa, MA, McCord, AM, and Kwak, LW. "Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 29, no. 20 (July 2011): 2787-2794. Full Text
  - Nalesnik, MA, Woodle, ES, Dimaio, JM, Vasudev, B, Teperman, LW, Covington, S, Taranto, S, Gockerman, JP, Shapiro, R, Sharma, V, Swinnen, LJ, Yoshida, A, and Ison, MG. "Donor-transmitted malignancies in organ transplantation: assessment of clinical risk." American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 11, no. 6 (June 2011): 1140-1147. Full Text
  - Zelenetz, AD, Abramson, JS, Advani, RH, Andreadis, CB, Bartlett, N, Bellam, N, Byrd, JC, Czuczman, MS, Fayad, LE, Glenn, MJ, Gockerman, JP, Gordon, LI, Harris, NL, Hoppe, RT, Horwitz, SM, Kelsey, CR, Kim, YH, LaCasce, AS, Nademanee, A, Porcu, P, Press, O, Pro, B, Reddy, N, Sokol, L, Swinnen, LJ, Tsien, C, Vose, JM, Wierda, WG, Yahalom, J, and Zafar, N. "Non-Hodgkin's lymphomas: Clinical practice guidelines in oncology." Jnccn Journal of the National Comprehensive Cancer Network 9, no. 5 (May 1, 2011): 484-560. (Review) Full Text
  - Bullock, KE, Petros, WP, Younis, I, Uronis, HE, Morse, MA, Blobe, GC, Zafar, SY, Gockerman, JP, Lager, JJ, Truax, R, Meadows, KL, Howard, LA, O'Neill, MM, Broadwater, G, Hurwitz, HI, and Bendell, JC. "A phase I study of bevacizumab (B) in combination with everolimus (E) and erlotinib (E) in advanced cancer (BEE)." Cancer Chemotherapy and Pharmacology 67, no. 2 (February 2011): 465-474. Full Text
  - Mowery, YM, Weinberg, JB, Kennedy, MN, Bond, KM, Moore, JO, Lanasa, MC, Gockerman, JP, Diehl, LF, Pizzo, SV, Cianciolo, GJ, and Friedman, DR. "LMP-420: a novel purine nucleoside analog with potent cytotoxic effects for CLL cells and minimal toxicity for normal hematopoietic cells." Leukemia 24, no. 9 (September 2010): 1580-1587. Full Text Link to Item
  - Crout, CA, Koh, L-P, Gockerman, JP, Moore, JO, Decastro, C, Long, GD, Diehl, L, Gasparetto, C, Niedzwiecki, D, Edwards, J, Prosnitz, L, Horwitz, M, Chute, J, Morris, A, Davis, P, Beaven, A, Chao, NJ, Ali-Osman, F, and Rizzieri, DA. "Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy." Cancer Invest 28, no. 6 (July 2010): 654-660. Full Text Link to Item
  - Zelenetz, AD, Abramson, JS, Advani, RH, Andreadis, CB, Byrd, JC, Czuczman, MS, Fayad, L, Forero, A, Glenn, MJ, Gockerman, JP, Gordon, LI, Harris, NL, Hoppe, RT, Horwitz, SM, Kaminski, MS, Kim, YH, Lacasce, AS, Mughal, TI, Nademanee, A, Porcu, P, Press, O, Prosnitz, L, Reddy, N, Smith, MR, Sokol, L, Swinnen, L, Vose, JM, Wierda, WG, Yahalom, J, and Yunus, F. "NCCN Clinical Practice Guidelines in Oncology: non-Hodgkin's lymphomas." Journal of the National Comprehensive Cancer Network : Jnccn 8, no. 3 (March 2010): 288-334. Full Text
  - Gasparetto, C, Gockerman, JP, Diehl, LF, de Castro, CM, Moore, JO, Long, GD, Horwitz, ME, Keogh, G, Chute, JP, Sullivan, KM, Neuwirth, R, Davis, PH, Sutton, LM, Anderson, RD, Chao, NJ, and Rizzieri, D. ""Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma." Biol Blood Marrow Transplant 16, no. 1 (January 2010): 70-77. Full Text Link to Item
  - Lanasa, MC, Allgood, SD, Volkheimer, AD, Gockerman, JP, Whitesides, JF, Goodman, BK, Moore, JO, Weinberg, JB, and Levesque, MC. "Single-cell analysis reveals oligoclonality among 'low-count' monoclonal B-cell lymphocytosis." Leukemia 24, no. 1 (January 2010): 133-140. Full Text Link to Item
  - Dugan, E, Truax, R, Meadows, KL, Blobe, GC, Morse, MA, Fernando, NH, Gockerman, JP, Petros, WP, and Hurwitz, HI. "Phase I dose escalation study of gemcitabine plus irinotecan in advanced solid tumors." Anticancer Research 29, no. 12 (December 2009): 5149-5153.
  - Friedman, DR, Weinberg, JB, Barry, WT, Goodman, BK, Volkheimer, AD, Bond, KM, Chen, Y, Jiang, N, Moore, JO, Gockerman, JP, Diehl, LF, Decastro, CM, Potti, A, and Nevins, JR. "A genomic approach to improve prognosis and predict therapeutic response in chronic lymphocytic leukemia." Clin Cancer Res 15, no. 22 (November 15, 2009): 6947-6955. Full Text Link to Item
  - Byrd, JC, Peterson, BL, Rai, KR, Hurd, D, Hohl, R, Perry, MC, Gockerman, J, Nattam, S, and Larson, RA. "Fludarabine followed by alemtuzumab consolidation for previously untreated chronic lymphocytic leukemia: Final report of Cancer and Leukemia Group B study 19901." Leukemia and Lymphoma 50, no. 10 (November 11, 2009): 1589-1596. Full Text
  - Smith, SM, Johnson, J, Cheson, BD, Canellos, G, Petroni, G, Oken, M, Duggan, D, Hurd, D, Gockerman, JP, Parker, B, Prchal, J, Peterson, BA, Cancer and Leukemia Group B, , and Eastern Cooperative Oncology Group, . "Recombinant interferon-alpha2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691." Leukemia & Lymphoma 50, no. 10 (October 2009): 1606-1617. Full Text
  - Rizzieri, DA, O'Brien, JA, Broadwater, G, Decastro, CM, Dev, P, Diehl, L, Beaven, A, Lagoo, A, Gockerman, JP, Chao, NJ, and Moore, JO. "Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia." Cancer 115, no. 13 (July 2009): 2922-2929. Full Text
  - Lanasa, MC, Allgood, SD, Bond, KM, Gockerman, JP, Levesque, MC, and Weinberg, JB. "Oligoclonal TRBV gene usage among CD8(+) T cells in monoclonal B lymphocytosis and CLL." British Journal of Haematology 145, no. 4 (May 2009): 535-537. Full Text
  - Shea, TC, Beaven, AW, Moore, DT, Serody, JS, Gabriel, DA, Chao, N, Gockerman, JP, Garcia, RA, and Rizzieri, DA. "Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival." Leuk Lymphoma 50, no. 5 (May 2009): 741-748. Full Text Link to Item
  - de Castro, C, Adams, D, Rizzieri, D, Moore, J, Gockerman, J, Diehl, L, Horwitz, M, Edmonds, E, and Warzecho, J. "P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromes." Leukemia Research 33, no. SUPPL. 1 (May 1, 2009). Full Text
  - de Castro, C, Adams, D, Rizzieri, D, Moore, J, Gockerman, J, Diehl, L, Horwitz, M, Edmonds, E, and Warzecho, J. "P129 A pilot study of decitabine in combination with arsenic trioxide for patients with myelodysplastic syndromes." Leukemia Research 33, no. SUPPL. 1 (May 1, 2009). Full Text
  - Weinberg, JB, Volkheimer, AD, Mihovilovic, M, Jiang, N, Chen, Y, Bond, K, Moore, JO, Gockerman, JP, Diehl, LF, de Castro, CM, Rizzieri, DA, Levesque, MC, Dekroon, R, and Strittmatter, WJ. "Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia." Leukemia 22, no. 12 (December 2008): 2184-2192. Full Text Link to Item
  - Armstrong, AJ, Creel, P, Turnbull, J, Moore, C, Jaffe, TA, Haley, S, Petros, W, Yenser, S, Gockerman, JP, Sleep, D, Hurwitz, H, and George, DJ. "A phase I-II study of docetaxel and atrasentan in men with castration-resistant metastatic prostate cancer." Clinical Cancer Research : an Official Journal of the American Association for Cancer Research 14, no. 19 (October 2008): 6270-6276. Full Text
  - Rao, AV, Younis, IR, Sand, GJ, Spasojevic, I, Adams, DJ, Decastro, CM, Gockerman, JP, Peterson, BL, Petros, WP, Moore, JO, and Rizzieri, DA. "Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia." Leukemia & Lymphoma 49, no. 8 (August 2008): 1523-1529. Full Text
  - Levesque, MC, Ghosh, DK, Beasley, BE, Chen, Y, Volkheimer, AD, O'Loughlin, CW, Gockerman, JP, Moore, JO, and Weinberg, JB. "CLL cell apoptosis induced by nitric oxide synthase inhibitors: correlation with lipid solubility and NOS1 dissociation constant." Leuk Res 32, no. 7 (July 2008): 1061-1070. Full Text Link to Item
  - Zafar, SY, Howell, DN, and Gockerman, JP. "Malignancy after solid organ transplantation: an overview." Oncologist 13, no. 7 (July 2008): 769-778. (Review) Full Text Link to Item
  - Zelenetz, AD, Advani, RH, Byrd, JC, Czuczman, MS, Damon, LE, Duvic, M, Fayad, L, Forero, A, Glenn, MJ, Gockerman, JP, Gordon, LI, Harris, NL, Hoppe, RT, Horwitz, SM, Kaminski, MS, Kim, YH, Lacasce, AS, Nademanee, A, Olsen, EA, Porcu, P, Press, O, Prosnitz, L, Smith, MR, Sotomayor, EM, Vose, JM, Yahalom, J, Yunus, F, and National Comprehensive Cancer Network, . "Non-Hodgkin's lymphomas." J Natl Compr Canc Netw 6, no. 4 (April 2008): 356-421. Link to Item
  - Ettinger, DS, Agulnik, M, Cristea, M, Eaton, K, Fidias, PM, Gockerman, JP, Hameed, O, Handorf, C, Harris, EI, Jacobs, CD, and al, E. "Occult primary: Clinical practice guidelines in oncology." JNCCN Journal of the National Comprehensive Cancer Network 6, no. 10 (2008): 1026-1060.
  - Sevilla, DW, Gong, JZ, Goodman, BK, Buckley, PJ, Rosoff, P, Gockerman, JP, and Lagoo, AS. "Clinicopathologic findings in high-grade B-cell lymphomas with typical Burkitt morphologic features but lacking the MYC translocation." Am J Clin Pathol 128, no. 6 (December 2007): 981-991. Full Text Link to Item
  - Weinberg, JB, Volkheimer, AD, Chen, Y, Beasley, BE, Jiang, N, Lanasa, MC, Friedman, D, Vaccaro, G, Rehder, CW, Decastro, CM, Rizzieri, DA, Diehl, LF, Gockerman, JP, Moore, JO, Goodman, BK, and Levesque, MC. "Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia." American Journal of Hematology 82, no. 12 (December 2007): 1063-1070. Full Text
  - DeAngelo, DJ, Yu, D, Johnson, JL, Coutre, SE, Stone, RM, Stopeck, AT, Gockerman, JP, Mitchell, BS, Appelbaum, FR, and Larson, RA. "Nelarabine induces complete remissions in adults with relapsed or refractory T-lineage acute lymphoblastic leukemia or lymphoblastic lymphoma: Cancer and Leukemia Group B study 19801." Blood 109, no. 12 (June 2007): 5136-5142. Full Text
  - Arcasoy, MO, and Gockerman, JP. "Aplastic anaemia as an autoimmune complication of thymoma." Br J Haematol 137, no. 4 (May 2007): 272-. Full Text Link to Item
  - Peterson, BA, Johnson, J, Shipp, MA, Barcos, M, Gockerman, JP, Canellos, GP, and Cancer and Leukemia Group B 9351, . "High dose CHOP: a phase II study of initial treatment in aggressive non-Hodgkin lymphoma. Cancer and Leukemia Group B 9351." Leukemia & Lymphoma 48, no. 5 (May 2007): 870-880. Full Text
  - Byrne, BJ, and Gockerman, JP. "Salvage therapy in Hodgkin's lymphoma." Oncologist 12, no. 2 (February 2007): 156-167. (Review) Full Text Link to Item
  - Rizzieri, DA, Koh, LP, Long, GD, Gasparetto, C, Sullivan, KM, Horwitz, M, Chute, J, Smith, C, Gong, JZ, Lagoo, A, Niedzwiecki, D, Dowell, JM, Waters-Pick, B, Liu, C, Marshall, D, Vredenburgh, JJ, Gockerman, J, Decastro, C, Moore, J, and Chao, NJ. "Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 25, no. 6 (February 2007): 690-697. Full Text
  - Volkheimer, AD, Weinberg, JB, Beasley, BE, Whitesides, JF, Gockerman, JP, Moore, JO, Kelsoe, G, Goodman, BK, and Levesque, MC. "Progressive immunoglobulin gene mutations in chronic lymphocytic leukemia: evidence for antigen-driven intraclonal diversification." Blood 109, no. 4 (February 2007): 1559-1567. Full Text
  - Zelenetz, AD, Advani, RH, Buadi, F, Cabanillas, F, Caligiuri, MA, Czuczman, MS, Damon, LE, Fayad, L, Flinn, IW, Forero, A, Glenn, MJ, Gockerman, JP, Gordon, LI, Harris, NL, Hoppe, RT, Kaminski, MS, Lacasce, AS, Nademanee, A, Porcu, P, Press, O, Prosnitz, L, Smith, MR, Sotomayor, EM, Vose, JM, Yahalom, J, and National Comprehensive Cancer Network, . "Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology." J Natl Compr Canc Netw 4, no. 3 (March 2006): 258-310. Link to Item
  - Koontz, BF, Kirkpatrick, JP, Clough, RW, Prosnitz, RG, Gockerman, JP, Moore, JO, and Prosnitz, LR. "Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications." J Clin Oncol 24, no. 4 (February 1, 2006): 605-611. Full Text Link to Item
  - Levesque, MC, Chen, Y, Beasley, BE, O'Loughlin, CW, Gockerman, JP, Moore, JO, and Weinberg, JB. "Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels." Leuk Res 30, no. 1 (January 2006): 24-28. Full Text Link to Item
  - Simsir, SA, Lin, SS, Blue, LJ, Gockerman, JP, Russell, SD, and Milano, CA. "Left ventricular assist device as destination therapy in doxorubicin-induced cardiomyopathy." Ann Thorac Surg 80, no. 2 (August 2005): 717-719. Full Text Link to Item
  - Neelapu, SS, Gause, BL, Nikcevich, DA, Schuster, SJ, Winter, J, Gockerman, JP, Loughran, T, Takeshita, K, Inghirami, G, McGaughey, D, Watson, TM, Snow, S, Kubovic, P, Ferraro, M, Jones, E, Jaffe, ES, Schwartzentruber, DJ, Danforth, D, Sherry, R, Kass, E, Van Waes, C, Reynolds, CW, and Kwak, LJ. "Phase III randomized trial of patient-specific vaccination for previously untreated patients with follicular lymphoma in first complete remission: protocol summary and interim report." Clin Lymphoma 6, no. 1 (June 2005): 61-64. Link to Item
  - Ettinger, DS, Arnoletti, JP, Gockerman, JP, Handorf, C, Havlin, KA, Jacobs, CD, Javle, M, Kvols, L, Lenzi, R, Rashid, A, Rhoades, CA, Ridge, JA, Saltz, L, Shulman, LN, Sondak, VK, Thompson, JA, Twardowski, P, Zhen, W, and National Comprehensive Cancer Network, . "Occult primary cancer clinical practice guidelines." Journal of the National Comprehensive Cancer Network : Jnccn 3, no. 2 (March 2005): 214-233.
  - Safford, SD, Coleman, RE, Gockerman, JP, Moore, J, Feldman, J, Onaitis, MW, Tyler, DS, and Olson, JA. "Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients." Cancer 101, no. 9 (November 2004): 1987-1993. Full Text
  - Talbot, J, Ibom, VK, Rizzieri, DA, Barrier, R, Niedzwieki, D, DeCastro, CM, Moore, JO, Buckley, P, Laney, R, Stevenson, D, Rumbaugh, H, and Gockerman, JP. "Dose-intense cyclophosphamide and etoposide for patients with refractory or high-risk non-Hodgkin's lymphoma." Clin Lymphoma 5, no. 2 (September 2004): 116-122. Link to Item
  - Rizzieri, DA, Akabani, G, Zalutsky, MR, Coleman, RE, Metzler, SD, Bowsher, JE, Toaso, B, Anderson, E, Lagoo, A, Clayton, S, Pegram, CN, Moore, JO, Gockerman, JP, DeCastro, C, Gasparetto, C, Chao, NJ, and Bigner, DD. "Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma." Blood 104, no. 3 (August 2004): 642-648. Full Text
  - Rizzieri, DA, Sand, GJ, McGaughey, D, Moore, JO, DeCastro, C, Chao, NJ, Vredenburgh, JJ, Gasparetto, C, Long, GD, Anderson, E, Foster, T, Toaso, B, Adams, D, Niedzwiecki, D, and Gockerman, JP. "Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma." Cancer 100, no. 11 (June 1, 2004): 2408-2414. Full Text Link to Item
  - Gluck, WL, Hurst, D, Yuen, A, Levine, AM, Dayton, MA, Gockerman, JP, Lucas, J, Denis-Mize, K, Tong, B, Navis, D, Difrancesco, A, Milan, S, Wilson, SE, and Wolin, M. "Phase I studies of interleukin (IL)-2 and rituximab in B-cell non-hodgkin's lymphoma: IL-2 mediated natural killer cell expansion correlations with clinical response." Clin Cancer Res 10, no. 7 (April 1, 2004): 2253-2264. Link to Item
  - Safford, SD, Coleman, RE, Gockerman, JP, Moore, J, Feldman, JM, Leight, GS, Tyler, DS, and Olson, JA. "Iodine -131 metaiodobenzylguanidine is an effective treatment for malignant pheochromocytoma and paraganglioma." Surgery 134, no. 6 (December 2003): 956-962. Full Text
  - Ibom, VK, Prosnitz, RG, Gong, JZ, Moore, JO, DeCastro, CM, Prosnitz, LR, Rizzieri, DA, and Gockerman, JP. "Rituximab in lymphocyte predominance Hodgkin's disease: a case series." Clin Lymphoma 4, no. 2 (September 2003): 115-118. Link to Item
  - Talbot, J, Rizzieri, DA, DeCastro, CM, Moore, JO, Buckley, P, Laney, R, Stevenson, D, Brumbaugh, H, and Gockerman, JP. "High-dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: a case series." Am J Hematol 73, no. 4 (August 2003): 295-296. (Letter) Full Text Link to Item
  - Advani, AS, Atkeson, B, Brown, CL, Peterson, BL, Fish, L, Johnson, JL, Gockerman, JP, and Gautier, M. "Barriers to the participation of African-American patients with cancer in clinical trials: a pilot study." Cancer 97, no. 6 (March 2003): 1499-1506. Full Text
  - Rizzieri, DA, Ibom, VK, Moore, JO, DeCastro, CM, Rosner, GL, Adams, DJ, Foster, T, Payne, N, Thompson, M, Vredenburgh, JJ, Gasparetto, C, Long, GD, Chao, NJ, and Gockerman, JP. "Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia." Clin Cancer Res 9, no. 2 (February 2003): 663-668. Link to Item
  - Bass, AJ, Gockerman, JP, Hammett, E, DeCastro, CM, Adams, DJ, Rosner, GL, Payne, N, Davis, P, Foster, T, Moore, JO, and Rizzieri, DA. "Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 20, no. 13 (July 2002): 2995-3000. Full Text
  - Shah, MA, Sanders, L, Lanclos, K, Chamis, AL, Gockerman, J, Wray, D, Corey, GR, and Fowler, VG. "Staphylococcus aureus bacteremia in patients with neutropenia." South Med J 95, no. 7 (July 2002): 782-784. (Letter) Link to Item
  - McCune, SL, Gockerman, JP, Moore, JO, Decastro, CM, Bass, AJ, Chao, NJ, Long, GD, Vredenburgh, JJ, Gasparetto, C, Adams, D, Payne, N, and Rizzieri, DA. "Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia." Leukemia & Lymphoma 43, no. 5 (May 2002): 1007-1011. Full Text
  - Rizzieri, DA, Bass, AJ, Rosner, GL, Gockerman, JP, DeCastro, CM, Petros, WP, Adams, DJ, Laughlin, MJ, Davis, P, Foster, T, Jacobson, R, Hurwitz, H, and Moore, JO. "Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 20, no. 3 (February 2002): 674-679. Full Text
  - McCune, SL, Gockerman, JP, and Rizzieri, DA. "Monoclonal antibody therapy in the treatment of non-Hodgkin lymphoma." JAMA 286, no. 10 (September 12, 2001): 1149-1152. (Review) Link to Item
  - Bartlett, NL, Petroni, GR, Parker, BA, Wagner, ND, Gockerman, JP, Omura, GA, Canellos, GP, Robert, M, Johnson, JL, and Peterson, BA. "Dose-escalated cyclophosphamide, doxorubicin, vincristine, prednisone, and etoposide (CHOPE) chemotherapy for patients with diffuse lymphoma: Cancer and Leukemia Group B studies 8852 and 8854." Cancer 92, no. 2 (July 2001): 207-217. Full Text
  - Rizzieri, DA, Gockerman, JP, Decastro, CM, Lilly, S, and Foster, T. "Phase i trial of continuously infused gemcitabine with cpt-11 for refractory hematologic malignancies." Blood 96, no. 11 PART II (December 1, 2000).
  - Agarwal, S, Gockerman, JP, Aldous, MD, and Swaim, MW. "Primary central nervous system lymphoma, presenting as diabetes insipidus, as a sequela of hepatitis C." Am J Med 107, no. 3 (September 1999): 303-304. (Letter) Link to Item
  - Liu, K, Mann, KP, Vitellas, KM, Paulson, EK, Nelson, RC, Gockerman, JP, and Dodd, LG. "Fine-needle aspiration with flow cytometric immunophenotyping for primary diagnosis of intra-abdominal lymphomas." Diagnostic cytopathology 21, no. 2 (August 1999): 98-104. (Academic Article)
  - Iselin, CE, Leder, RA, Lacey, J, Gockerman, JP, and Paulson, DF. "Renal lymphoma in an azotemic patient--usefulness of magnetic resonance imaging." Scand J Urol Nephrol 33, no. 2 (April 1999): 129-130. Link to Item
  - Lau, CL, Bentley, RC, Gockerman, JP, Que, LG, and D'Amico, TA. "Malignant melanoma presenting as a mediastinal mass." Ann Thorac Surg 67, no. 3 (March 1999): 851-852. Link to Item
  - Perry, JR, Brown, MT, and Gockerman, JP. "Acute leukemia following treatment of malignant glioma." J Neurooncol 40, no. 1 (October 1998): 39-46. (Review) Link to Item
  - Hanson, MW, Schneider, AM, Enterline, DS, Feldman, JM, and Gockerman, JP. "Iodine-131-metaiodobenzylguanidine uptake in metastatic carcinoid tumor to the orbit." J Nucl Med 39, no. 4 (April 1998): 647-650. Link to Item
  - Laughlin, MJ, McGaughey, DS, Crews, JR, Chao, NJ, Rizzieri, D, Ross, M, Gockerman, J, Cirrincione, C, Berry, D, Mills, L, Defusco, P, LeGrand, S, Peters, WP, and Vredenburgh, JJ. "Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant." J Clin Oncol 16, no. 3 (March 1998): 1008-1012. Full Text Link to Item
  - Williams, E, Rizzieri, DA, and Gockerman, JP. "Thrombocytosis associated with low-molecular-weight heparin [6] (multiple letters)." Annals of Internal Medicine 126, no. 9 (1997): 742-743.
  - Rizzieri, DA, Wong, WM, and Gockerman, JP. "Thrombocytosis associated with low-molecular-weight heparin." Ann Intern Med 125, no. 2 (July 15, 1996): 157-. (Letter) Link to Item
  - Shami, PJ, Moore, JO, Gockerman, JP, Hathorn, JW, Misukonis, MA, and Weinberg, JB. "Nitric oxide modulation of the growth and differentiation of freshly isolated acute non-lymphocytic leukemia cells." Leuk Res 19, no. 8 (August 1995): 527-533. Link to Item
  - Brown, MT, McClendon, RE, and Gockerman, JP. "Primary central nervous system lymphoma with systemic metastasis: case report and review." J Neurooncol 23, no. 3 (1995): 207-221. (Review) Link to Item
  - Lachance, DH, Brizel, DM, Gockerman, JP, Halperin, EC, Burger, PC, Boyko, OB, Brown, MT, and Schold, SC. "Cyclophosphamide, doxorubicin, vincristine, and prednisone for primary central nervous system lymphoma: short-duration response and multifocal intracerebral recurrence preceding radiotherapy." Neurology 44, no. 9 (September 1994): 1721-1727. Link to Item
  - Brizel, DM, Gockerman, JP, Crawford, J, Hathorn, JW, Moore, JO, Osborne, B, and Prosnitz, LR. "A pilot study of etoposide, vinblastine, and doxorubicin plus involved field irradiation in advanced, previously untreated Hodgkin's disease." Cancer 74, no. 1 (July 1994): 159-163. Full Text
  - Glantz, MJ, Biran, H, Myers, ME, Gockerman, JP, and Friedberg, MH. "The radiographic diagnosis and treatment of paraneoplastic central nervous system disease." Cancer 73, no. 1 (January 1994): 168-175. (Review) Full Text
  - Gockerman, JP, Halperin, EC, Magrinat, GC, Hendrix, BM, and Peters, WP. "Physician-assisted suicide and advance directives concerning life support." N C Med J 54, no. 7 (July 1993): 312-316. Link to Item
  - Ortel, TL, Gockerman, JP, Califf, RM, McCann, RL, O'Connor, CM, Metzler, DM, and Greenberg, CS. "Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis." Thrombosis and Haemostasis 67, no. 3 (March 1992): 292-296.
  - Persons, DA, Laughlin, M, Tanner, D, Perfect, J, Gockerman, JP, and Hathorn, JW. "Fluconazole and Candida krusei fungemia." N Engl J Med 325, no. 18 (October 31, 1991): 1315-. (Letter) Link to Item
  - Higa, GM, Gockerman, JP, Hunt, AL, Jones, MR, and Horne, BJ. "The use of prophylactic eye drops during high-dose cytosine arabinoside therapy." Cancer 68, no. 8 (October 1991): 1691-1693. Full Text
  - Brizel, DM, Winer, EP, Prosnitz, LR, Scott, J, Crawford, J, Moore, JO, and Gockerman, JP. "Improved survival in advanced Hodgkin's disease with the use of combined modality therapy." Int J Radiat Oncol Biol Phys 19, no. 3 (September 1990): 535-542. Link to Item
  - Jones, RB, Shpall, EJ, Shogan, J, Affronti, ML, Coniglio, D, Hart, L, Halperin, E, Iglehart, JD, Moore, J, and Gockerman, J. "The Duke AFM Program. Intensive induction chemotherapy for metastatic breast cancer." Cancer 66, no. 3 (August 1990): 431-436. Full Text
  - Laszlo, J, Goldstein, D, Gockerman, J, Hood, L, Huang, AT, Triozzi, P, Sedwick, WD, Koren, H, Ellinwood, EH, and Tso, CY. "Phase I studies of recombinant interferon-γ." Journal of Biological Response Modifiers 9, no. 2 (1990): 185-193.
  - Kaufman, PA, Gockerman, JP, and Greenberg, CS. "Production of a novel anticoagulant by neoplastic plasma cells: report of a case and review of the literature." The American Journal of Medicine 86, no. 5 (May 1989): 612-616. Full Text
  - Borowitz, MJ, Gockerman, JP, Moore, JO, Civin, CI, Page, SO, Robertson, J, and Bigner, SH. "Clinicopathologic and cytogenic features of CD34 (My 10)-positive acute nonlymphocytic leukemia." Am J Clin Pathol 91, no. 3 (March 1989): 265-270. Link to Item
  - Peters, WP, Stuart, A, Klotman, M, Gilbert, C, Jones, RB, Shpall, EJ, Gockerman, J, Bast, RC, and Moore, JO. "High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic study." Cancer Chemotherapy and Pharmacology 23, no. 6 (January 1989): 377-383. Full Text
  - Peters, WP, Shpall, EJ, Jones, RB, Olsen, GA, Bast, RC, Gockerman, JP, and Moore, JO. "High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer." J Clin Oncol 6, no. 9 (September 1988): 1368-1376. Full Text Link to Item
  - Olsen, GA, Gockerman, JP, Bast, RC, Borowitz, M, and Peters, WP. "Altered immunologic reconstitution after standard-dose chemotherapy or high-dose chemotherapy with autologous bone marrow support." Transplantation 46, no. 1 (July 1988): 57-60. Link to Item
  - Sokal, JE, Gockerman, JP, and Bigner, SH. "Evidence for a selective antileukemic effect of cytosine arabinoside in chronic granulocytic leukemia." Leuk Res 12, no. 6 (1988): 453-458. Link to Item
  - Peters, WP, Henner, WD, Grochow, LB, Olsen, G, Edwards, S, Stanbuck, H, Stuart, A, Gockerman, J, Moore, J, and Bast, RC. "Clinical and pharmacologic effects of high dose single agent busulfan with autologous bone marrow support in the treatment of solid tumors." Cancer Res 47, no. 23 (December 1, 1987): 6402-6406. Link to Item
  - Kurlander, R, Coleman, RE, Moore, J, Gockerman, J, Rosse, W, and Siegal, R. "Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gamma globulin in the treatment of immune thrombocytopenic purpura in adults." The American Journal of Medicine 83, no. 4 SUPPL. 1 (October 23, 1987): 17-24. Full Text
  - Gockerman, JP, Silberman, H, and Bartolucci, AA. "Phase II evaluation of aclarubicin in refractory multiple myeloma: a Southeastern Cancer Study Group Trial." Cancer Treat Rep 71, no. 7-8 (July 1987): 773-774. Link to Item
  - Barton, JC, Prasthofer, EF, Gockerman, JP, and Grossi, CE. "Immune deficiency and expanded population of granular lymphocytes after bone marrow transplantation." Am J Med 82, no. 5 (May 1987): 1086-1087. (Letter) Link to Item
  - Goldstein, D, Gockerman, J, Krishnan, R, Jr, JR, Tso, CY, Hood, LE, Ellinwood, E, and Laszlo, J. "Effects of γ-interferon on the endocrine system: Results from a phase I study." Cancer Research 47, no. 23 (1987): 6397-6401.
  - Gockerman, JP, Spremulli, EN, Raney, M, and Logan, T. "Randomized comparison of tamoxifen versus diethylstilbestrol in estrogen receptor-positive or -unknown metastatic breast cancer: a Southeastern Cancer Study Group trial." Cancer Treat Rep 70, no. 10 (October 1986): 1199-1203. Link to Item
  - Gockerman, JP, Bartolucci, AA, Nelson, MO, Silberman, H, Velez-Garcia, E, and Stein, R. "Phase II evaluation of etoposide in refractory multiple myeloma: a Southeastern Cancer Study Group Trial." Cancer Treat Rep 70, no. 6 (June 1986): 801-802. Link to Item
  - Kramer, BS, Birch, R, Gockerman, JP, Greco, A, and Prestridge, K. "Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial." Cancer Treatment Reports 70, no. 6 (June 1986): 803-804.
  - Triozzi, PL, Borowitz, MJ, and Gockerman, JP. "Gastrointestinal involvement and multiple lymphomatous polyposis in mantle-zone lymphoma." J Clin Oncol 4, no. 6 (June 1986): 866-873. Full Text Link to Item
  - Gockerman, JP, Raney, M, and Logan, T. "Phase II evaluation of aclarubicin in advanced breast cancer: a Southeastern Cancer Study Group trial." Cancer Treat Rep 69, no. 9 (September 1985): 1029-1030. Link to Item
  - Wise, RH, Shin, MS, Gockerman, JP, Zornes, SL, Rubin, E, and Nath, PH. "Pneumonia in bone marrow transplant patients." AJR Am J Roentgenol 143, no. 4 (October 1984): 707-714. Full Text Link to Item
  - Rodu, B, Griffin, IL, and Gockerman, JP. "Oral candidiasis in cancer patients." South Med J 77, no. 3 (March 1984): 312-314. Link to Item
  - Johnson, FL, Look, AT, Gockerman, J, Ruggiero, MR, Dalla-Pozza, L, and III, FTB. "Bone-marrow transplantation in a patient with sickle-cell anemia." New England Journal of Medicine 311, no. 12 (1984): 780-783.
  - Rodu, B, and Gockerman, JP. "Oral manifestations of the chronic graft-v-host reaction." Jama 249, no. 4 (January 1983): 504-507. Full Text
  - Gockerman, JP. "Drug-induced interstitial lung diseases." Clin Chest Med 3, no. 3 (September 1982): 521-536. (Review) Link to Item
  - Kirchner, KA, Smith, RM, Gockerman, JP, and Luke, RG. "Hereditary thrombotic thrombocytopenic purpura: microangiopathic hemolytic anemia, thrombocytopenia, and renal insufficiency occurring in consecutive generations." Nephron 30, no. 1 (1982): 28-30. Full Text Link to Item
  - Marciniak, E, and Gockerman, JP. "Kinetics of elimination of antithrombin III concentrate in heparinized patients." Br J Haematol 48, no. 4 (August 1981): 617-625. Link to Item
  - Gockerman, JP. "Allogeneic bone marrow transplantation for aplastic anemia and acute leukemia." Ala J Med Sci 18, no. 3 (July 1981): 235-239. Link to Item
  - Goldenberg, DM, Kim, EE, Deland, F, Spremulli, E, Nelson, MO, Gockerman, JP, Primus, FJ, Corgan, RL, and Alpert, E. "Clinical studies on the radioimmunodetection of tumors containing alpha-fetoprotein." Cancer 45, no. 10 (May 1980): 2500-2505. Full Text
  - Gockerman, JP, and Jacob, W. "Purification and characterization of papain-solubilized HLA antigens from human platelets." Blood 53, no. 5 (May 1979): 838-850. Link to Item
  - Gockerman, JP. "The lipids of the erythrocyte in paroxysmal nocturnal hemoglobinuria." Am J Hematol 5, no. 4 (1978): 323-333. Link to Item
  - Marciniak, E, and Gockerman, JP. "Heparin-induced decrease in circulating antithrombin-III." Lancet 2, no. 8038 (September 17, 1977): 581-584. Link to Item
  - Gockerman, JP, and Brouillard, RP. "RBC transfusions in paroxysmal nocturnal hemoglobinuria." Archives of Internal Medicine 137, no. 4 (April 1977): 536-538. Full Text
  - Marciniak, E, and Gockerman, JP. "Effect of heparin on circulating antithrombin III level." Thrombosis and Haemostasis 38, no. 1 (January 1, 1977): 77-null.
  - Marciniak, E, and Gockerman, JP. "Effect of heparin therapy on antithrombin III." Clinical Research 25, no. 3 (January 1, 1977).
  - Kimball, DB, Rickles, FR, Gockerman, JP, Hattler, BG, Light, JA, and Conrad, ME. "Procoagulant and platelet aggregating properties of antilymphocyte sera." J Lab Clin Med 87, no. 5 (May 1976): 868-881. Link to Item
  - Gockerman, JP, Durocher, JR, and Conrad, ME. "The abnormal surface characteristics of the red blood cell membrane in congenital dyserythropoietic anaemia type II (HEMPAS)." Br J Haematol 30, no. 4 (August 1975): 383-394. Link to Item
  - Joseph, KC, and Gockerman, JP. "Accumulation of glycolipids containing N-acetylglucosamine in erythrocyte stroma of patients with congenital dyserythropoietic anemia type II (HEMPAS)." Biochem Biophys Res Commun 65, no. 1 (July 8, 1975): 146-152. Link to Item
  - Alving, CR, Conrad, DH, Gockerman, JP, Gibbs, MB, and Wirtz, GH. "Vitamin A in liposomes. Inhibition of complement binding and alteration of membrane structure." Biochim Biophys Acta 394, no. 2 (June 25, 1975): 157-165. Link to Item
  - Durocher, JR, Gockerman, JP, and Conrad, ME. "Alteration of human erythrocyte membrane properties by complement fixation." J Clin Invest 55, no. 4 (April 1975): 675-680. Full Text Link to Item
  - Gockerman, JP, Bowman, RP, and Conrad, ME. "Detection of platelet isoantibodies by (3H)serotonin platelet release and its clinical application to the problem of platelet matching." J Clin Invest 55, no. 1 (January 1975): 75-83. Full Text Link to Item
  - Joseph, KC, Gockerman, JP, and Alving, CR. "Abnormal lipid composition of the red cell membrane in congenital dyserythropoietic anemia type II (HEMPAS)." J Lab Clin Med 85, no. 1 (January 1975): 34-40. Link to Item
  - Joseph, KC, and Gockerman, JP. "Accumulations of N acetyl glucosamine containing glycolipids in erythrocyte stroma of patients with congenial dyserythropoietic anemia type II (HEMPAS)." Clinical Research 23, no. 3 (January 1, 1975).
  - Gockerman, JP, and Shulman, NR. "Isoantibody specificity in post-transfusion purpura." Blood 41, no. 6 (June 1973): 817-822. Link to Item
  - Logue, GL, Rosse, WF, and Gockerman, JP. "Measurement of the third component of complement bound to red blood cells in patients with the cold agglutinin syndrome." J Clin Invest 52, no. 2 (February 1973): 493-501. Full Text Link to Item
  - Enquist, RW, Gockerman, JP, Jenis, EH, Warkel, RL, and Dillon, DE. "Type II congenital dyserythropoietic anemia." Ann Intern Med 77, no. 3 (September 1972): 371-376. Link to Item
  - ALLEN, JM, and GOCKERMAN, J. "ELECTROPHORETIC SEPARATION OF MULTIPLE FORMS OF PARTICLE ASSOCIATED." Annals of the New York Academy of Sciences 121 (1964): 616-633.

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

Selected Grants

Selected Publications

Academic Articles